TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36273203

Group type: COMPARATOR
Intervention: Current standard-of-care anticoagulation practice
Number of subjects: 15000

Group type: EXPERIMENTAL
Intervention: HA-VTE risk probability calculated from a validated VTE risk-prediction model with daily updates; additional review by hematologists for patients with elevated risk (predicted probability of HA-VTE ≥ 0.025) including recommendations for pharmacologic prophylaxis if appropriate.
Number of subjects: 15000
Study: 32270182

Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) intervention
Number of subjects: 1635

Group type: COMPARATOR
Intervention: Health Education (HE)
Number of subjects: 1635
Study: 35860187

Group type: EXPERIMENTAL
Intervention: ICGA + ICAC + perioperative nursing
Number of subjects: 86

Group type: COMPARATOR
Intervention: ICAC + conventional nursing
Number of subjects: 86
Study: 33172456

Group type: EXPERIMENTAL
Intervention: Er:YAG laser pre-treatment (energy 50-300 mJ, frequency 5-30 Hz)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Conventional acid etching treatment
Number of subjects: 4
Study: 33174761

Group type: EXPERIMENTAL
Intervention: Bare-metal stent plus 1 mg of colchicine for 3 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Drug-eluting stent alone
Number of subjects: 0
Study: 35183498

Group type: EXPERIMENTAL
Intervention: Isonicotinic acid hydrazide (INH) 900 mg vaginally
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33821679

Group type: EXPERIMENTAL
Intervention: Tu’Washindi na PrEP intervention
Number of subjects: 0
Study: 32951737

Group type: EXPERIMENTAL
Intervention: Watching comedy movies during dialysis (experimental group)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 61
Study: 35880807

Group type: EXPERIMENTAL
Intervention: Intensive diabetes therapy
Number of subjects: 1094

Group type: COMPARATOR
Intervention: Conventional diabetes therapy
Number of subjects: 1094

Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 1094
Study: 34076966

Group type: EXPERIMENTAL
Intervention: CPT-11 (60 mg/m2 on days 1 and 8) every three weeks
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: AMR (35 mg/m2 on days 1–3) every three weeks
Number of subjects: 14

Group type: COMPARATOR
Intervention: CPT-11
Number of subjects: 14

Group type: COMPARATOR
Intervention: AMR
Number of subjects: 14
Study: 35867857

Group type: EXPERIMENTAL
Intervention: Study group (n = 39) received spinal anesthesia with intrathecal morphine, periarticular local anesthesia infiltration, intravenous dexamethasone, single injection adductor canal block, plus five additional interventions: local anesthetic infiltration between the popliteal artery and capsule of the posterior knee, intraoperative intravenous dexmedetomidine and ketamine, one additional intravenous dexamethasone bolus, and two additional adductor canal block injections.
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control group (n = 39) received spinal anesthesia with intrathecal morphine, periarticular local anesthesia infiltration, intravenous dexamethasone, and a single injection adductor canal block.
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Study group (n = 39)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control group (n = 39)
Number of subjects: 78
Study: 34198135

Group type: EXPERIMENTAL
Intervention: Active tDCS (2.0 mA)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Sham stimulation (0.3 mA)
Number of subjects: 44
Study: 35846796

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control (normal saline)
Number of subjects: 120
Study: 34914726

Group type: EXPERIMENTAL
Intervention: Trivalent influenza vaccine
Number of subjects: 554

Group type: EXPERIMENTAL
Intervention: Probiotic supplement (Lactobacillus helveticus R0052 and Lactobacillus rhamnosus R0011)
Number of subjects: 554

Group type: COMPARATOR
Intervention: Influenza vaccine
Number of subjects: 554

Group type: COMPARATOR
Intervention: Probiotic group
Number of subjects: 554
Study: 33008780

Group type: EXPERIMENTAL
Intervention: Watching a relaxing video during cystoscopy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no video)
Number of subjects: 60
Study: 35338847

Group type: EXPERIMENTAL
Intervention: 2.5 g/day of n‐3 PUFA
Number of subjects: 193

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 193
Study: 32379227

Group type: EXPERIMENTAL
Intervention: Taylor Spatial Frame (TSF)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Reamed intramedullary nailing (IMN)
Number of subjects: 63
Study: 34142339

Group type: EXPERIMENTAL
Intervention: Baseline SBP increase of 10 mm Hg
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Pre-recanalization SBP increase of 10 mm Hg
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Baseline MAP increase of 10 mm Hg
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Pre-recanalization MAP increase of 10 mm Hg
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: SBP of 163 mm Hg and MAP of 117 mm Hg during pre-recanalization phase
Number of subjects: 139
Study: 35485357

Group type: EXPERIMENTAL
Intervention: HIIT (5 x 1 min at 80-95% maximal heart rate, twice weekly for 12 weeks)
Number of subjects: 46

Group type: COMPARATOR
Intervention: CON (no exercise, nutritional counseling for weight loss)
Number of subjects: 46
Study: 34791778

Group type: EXPERIMENTAL
Intervention: Happy-sounding music
Number of subjects: 75

Group type: COMPARATOR
Intervention: Sad-sounding music
Number of subjects: 75
Study: 34263654

Group type: EXPERIMENTAL
Intervention: Deep brain stimulation (DBS) for OCD
Number of subjects: 4
Study: 34075813

Group type: EXPERIMENTAL
Intervention: Apixaban dose adjustment based on age, weight, and serum creatinine in NVAF.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pharmacokinetic studies of apixaban in patients >65 years, those with extreme body weights, and those with advanced renal impairment.
Number of subjects: 0
Study: 34219572

Group type: EXPERIMENTAL
Intervention: Reactions to Homosexuality Scale (RHS)
Number of subjects: 5573
Study: 33248546

Group type: EXPERIMENTAL
Intervention: 16 m‐2 stocking density (high stocking density, HSD)
Number of subjects: 1440

Group type: EXPERIMENTAL
Intervention: 16 m‐2 stocking density (HSD)
Number of subjects: 1440
Study: 35279070

Group type: EXPERIMENTAL
Intervention: TraumaApp (digital data collection tool)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: System Usability Score for TraumaApp
Number of subjects: 50

Group type: COMPARATOR
Intervention: Paper proforma (control)
Number of subjects: 50
Study: 33059195

Group type: EXPERIMENTAL
Intervention: TMP-SMX prophylaxis
Number of subjects: 61

Group type: COMPARATOR
Intervention: Second-line medications (inhaled pentamidine, dapsone, atovaquone)
Number of subjects: 61
Study: 34980495

Group type: EXPERIMENTAL
Intervention: Enzalutamide
Number of subjects: 42

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Androgen deprivation therapy (ADT)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Bicalutamide or ADT
Number of subjects: 42
Study: 36147791

Group type: EXPERIMENTAL
Intervention: Platelet-Rich Plasma (PRP)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Microfragmented Adipose Tissue (MFAT)
Number of subjects: 58
Study: 32155257

Group type: EXPERIMENTAL
Intervention: MR-Egger
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MR-DoC
Number of subjects: 0
Study: 35320363

Group type: EXPERIMENTAL
Intervention: Fenofibrate
Number of subjects: 5518

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5518
Study: 34345969

Group type: EXPERIMENTAL
Intervention: Pre‐emptive antibiotic treatment with clarithromycin (200 mg twice per day) during panitumumab treatment.
Number of subjects: 156

Group type: COMPARATOR
Intervention: Control group with skin care only.
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Pre‐emptive group (clarithromycin).
Number of subjects: 156

Group type: COMPARATOR
Intervention: Control group (skin care only).
Number of subjects: 156
Study: 32147077

Group type: EXPERIMENTAL
Intervention: Curcumin 1000 mg/day for 12 weeks
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 70
Study: 35366069

Group type: EXPERIMENTAL
Intervention: Proprioceptive training with feedback (PTWF)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Proprioceptive training no feedback (PTNF)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control (CTRL)
Number of subjects: 72
Study: 32167011

Group type: EXPERIMENTAL
Intervention: Anti-CS6 BSIgG
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Anti-B7A BSIgG
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo (non-hyperimmune BSIgG)
Number of subjects: 59
Study: 33598681

Group type: EXPERIMENTAL
Intervention: Remote work
Number of subjects: 112

Group type: COMPARATOR
Intervention: Diet, physical activity, and workday sedentary behaviour
Number of subjects: 112
Study: 35319604

Group type: EXPERIMENTAL
Intervention: Rotary (Hyflex EDM®) technique
Number of subjects: 40

Group type: COMPARATOR
Intervention: Manual (k-file) technique
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Restoration retention
Number of subjects: 40
Study: 32208040

Group type: EXPERIMENTAL
Intervention: Endoscopic treatment for esophageal GISTs
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Preoperative endoscopic biopsy
Number of subjects: 16
Study: 33803720

Group type: EXPERIMENTAL
Intervention: Progressive Step Marching Exercise (PSME) program for 8 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (normal activity)
Number of subjects: 60
Study: 32323437

Group type: EXPERIMENTAL
Intervention: iGlarLixi
Number of subjects: 0

Group type: COMPARATOR
Intervention: GLP-1 RA
Number of subjects: 0
Study: 34645649

Group type: EXPERIMENTAL
Intervention: letrozole for 14 weeks
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: letrozole for 2 weeks, then letrozole+palbociclib for 14 weeks
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: palbociclib for 2 weeks, then letrozole+palbociclib for 14 weeks
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: letrozole+palbociclib for 14 weeks
Number of subjects: 307

Group type: COMPARATOR
Intervention: palbociclib
Number of subjects: 307
Study: 33559351

Group type: EXPERIMENTAL
Intervention: Stryphnodendron adstringens (SA) at 3000 mg/L
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Lafoensia pacari (LP) at 300 mg/L
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Copaifera spp. (CO) at 300 mg/L
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Pterodon emarginatus (PE) at 30 and 300 mg/L
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Stryphnodendron adstringens (SA) at 300 mg/L
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Lafoensia pacari (LP) at 30 mg/L
Number of subjects: 8
Study: 33169920

Group type: EXPERIMENTAL
Intervention: ThymLec 2%
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ThymLec 2% (in vitro)
Number of subjects: 0
Study: 32056917

Group type: EXPERIMENTAL
Intervention: Comorbid PTSD
Number of subjects: 482
Study: 35149571

Group type: EXPERIMENTAL
Intervention: Multicomponent, multidisciplinary implementation intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (preintervention period)
Number of subjects: 0
Study: 34977544

Group type: EXPERIMENTAL
Intervention: TIMP (45 minutes)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: TIMP+cMI (30 minutes TIMP, 15 minutes metronome-cued motor imagery)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: TIMP+MI (30 minutes TIMP, 15 minutes motor imagery without cues)
Number of subjects: 30
Study: 35452918

Group type: EXPERIMENTAL
Intervention: Accelerated access to physiotherapy
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Personalised approach with a physiotherapist
Number of subjects: 33
Study: 33307626

Group type: EXPERIMENTAL
Intervention: Selective retina therapy (SRT)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control (sham treatment)
Number of subjects: 68
Study: 33722790

Group type: EXPERIMENTAL
Intervention: Combined phacoemulsification plus ECP
Number of subjects: 48

Group type: COMPARATOR
Intervention: Phacoemulsification alone
Number of subjects: 48
Study: 32654089

Group type: EXPERIMENTAL
Intervention: Hazard ratio
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Causal hazard ratio
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Causal hazard difference
Number of subjects: 0
Study: 32105007

Group type: EXPERIMENTAL
Intervention: Mothers' behavior concerning the prevention of poisoning in children under the age of five years
Number of subjects: 580

Group type: EXPERIMENTAL
Intervention: Mothers' related knowledge and HBM constructs
Number of subjects: 580
Study: 35948694

Group type: EXPERIMENTAL
Intervention: Rate discrimination training for 100- and 300-Hz pulse trains
Number of subjects: 77

Group type: COMPARATOR
Intervention: Tone detection in noise (active control)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Rate discrimination training
Number of subjects: 77
Study: 33430695

Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid (CSF) SUR1 expression in TBI patients
Number of subjects: 23

Group type: COMPARATOR
Intervention: Cerebrospinal fluid (CSF) SUR1 expression in controls
Number of subjects: 23
Study: 32103542

Group type: EXPERIMENTAL
Intervention: Internet-based intervention (PTSD Clinicians Exchange) with ongoing access to resources and biweekly email reminders.
Number of subjects: 605

Group type: COMPARATOR
Intervention: Newsletter-only control condition.
Number of subjects: 605
Study: 35654589

Group type: EXPERIMENTAL
Intervention: Highest plasma sDPP4 quartile
Number of subjects: 3564
Study: 34377137

Group type: EXPERIMENTAL
Intervention: Zataria multiflora (ZM) extract syrup
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 35931415

Group type: EXPERIMENTAL
Intervention: HRV biofeedback before sleep
Number of subjects: 8
Study: 33420265

Group type: EXPERIMENTAL
Intervention: Risk model based on eight factors (age, ingestion volume, CK-MB, PLT, WBC, N, GGT, Cr)
Number of subjects: 1199
Study: 33587552

Group type: EXPERIMENTAL
Intervention: Linear model using the 20mSRT (laps), body mass index, and body fat percentage.
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Allometric model using the 20mSRT (laps), height, and body mass.
Number of subjects: 148
Study: 32643674

Group type: EXPERIMENTAL
Intervention: SGB with 10 mL of 0.5% bupivacaine (Group B)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (Group S)
Number of subjects: 60
Study: 36342703

Group type: EXPERIMENTAL
Intervention: Daily low-dose aspirin (100 mg)
Number of subjects: 16703

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16703
Study: 33035140

Group type: EXPERIMENTAL
Intervention: Continuous androgen deprivation therapy (agonist or antagonist)
Number of subjects: 838
Study: 32436638

Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 14443

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 14443
Study: 35113042

Group type: EXPERIMENTAL
Intervention: Propofol anesthesia
Number of subjects: 1259

Group type: COMPARATOR
Intervention: Sevoflurane anesthesia
Number of subjects: 1259
Study: 32725500

Group type: EXPERIMENTAL
Intervention: 2.5 U of abobotulinumtoxinA (ABO) per side for mild GS
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: 5 U of abobotulinumtoxinA (ABO) per side for moderate GS
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: 2.5 U, 5 U, or 7.5 U of abobotulinumtoxinA (ABO) per side for severe GS
Number of subjects: 41
Study: 35921117

Group type: EXPERIMENTAL
Intervention: Neoadjuvant Chemoradiotherapy Plus Surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 34028794

Group type: EXPERIMENTAL
Intervention: Laparoscopy or laparotomy
Number of subjects: 471

Group type: EXPERIMENTAL
Intervention: Gynaecology unit
Number of subjects: 471

Group type: EXPERIMENTAL
Intervention: Pelvic pain intensity
Number of subjects: 471

Group type: EXPERIMENTAL
Intervention: Lower parity
Number of subjects: 471

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 471
Study: 32555986

Group type: EXPERIMENTAL
Intervention: Incremental exhaustive cycling
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Incremental exhaustive running
Number of subjects: 17
Study: 35619617

Group type: EXPERIMENTAL
Intervention: Transcutaneous Electrical Cranial-Auricular Acupoint Stimulation (TECAS)
Number of subjects: 470

Group type: COMPARATOR
Intervention: Escitalopram
Number of subjects: 470
Study: 32408361

Group type: EXPERIMENTAL
Intervention: 22G Acquire needle
Number of subjects: 60

Group type: COMPARATOR
Intervention: 20G Procore needle
Number of subjects: 60
Study: 35479268

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group (Guideline-Based Physical Activity)
Number of subjects: 180
Study: 33818314

Group type: COMPARATOR
Intervention: Exercise group (E)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy group (LLLT)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Manual pressure release group (MPR)
Number of subjects: 75
Study: 35446848

Group type: EXPERIMENTAL
Intervention: SUVfdg
Number of subjects: 481
Study: 35837981

Group type: EXPERIMENTAL
Intervention: TOTUM-63 (5 g/day)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 34757564

Group type: EXPERIMENTAL
Intervention: Physical activity intervention over 24 months
Number of subjects: 98

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 98
Study: 35147118

Group type: EXPERIMENTAL
Intervention: Shengyu Decoction
Number of subjects: 0
Study: 33735707

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) treatment for 16 weeks
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo treatment for 16 weeks
Number of subjects: 49
Study: 32997869

Group type: EXPERIMENTAL
Intervention: Acupuncture (G1)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control (TENS, G2)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Acupuncture (G1) and Control (TENS, G2)
Number of subjects: 28
Study: 35366858

Group type: EXPERIMENTAL
Intervention: Seminar-case learning (SCL) method
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional lecture-based learning (LBL) model
Number of subjects: 0
Study: 33094470

Group type: EXPERIMENTAL
Intervention: Aspergillus section Nigri strains identified through multiplex PCR
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Partial sequencing of the CaM gene
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Detection of fum8 gene in A. welwitschiae isolates
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Detection of radH and pks genes in A. welwitschiae isolates
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Association of fum8 gene presence with fumonisin production
Number of subjects: 96
Study: 34903983

Group type: EXPERIMENTAL
Intervention: Hypertonic saline solution (HSS) 150 mL
Number of subjects: 28

Group type: COMPARATOR
Intervention: Normal saline 150 mL
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Both groups received 250 mg IV furosemide every 12 h for 48 h
Number of subjects: 28
Study: 32487038

Group type: EXPERIMENTAL
Intervention: Stereotactic ablative radiation (SABR) + radium-223 dichloride (6 infusions at 4-week intervals)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Stereotactic ablative radiation (SABR) alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SABR + radium-223 dichloride
Number of subjects: 0

Group type: COMPARATOR
Intervention: SABR alone
Number of subjects: 0
Study: 32997242

Group type: EXPERIMENTAL
Intervention: Copper (Cu) at 1.25 ppm for 96 h and then 20, 30, and 40% for 30 days
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Cadmium (Cd) at 4.5 ppm for 96 h and then 20, 30, and 40% for 30 days
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Mixture of Cu and Cd at 2.25 ppm for 96 h and then 20, 30, and 40% for 30 days
Number of subjects: 4

Group type: COMPARATOR
Intervention: Control group (not exposed to Cu or Cd)
Number of subjects: 4
Study: 33009448

Group type: EXPERIMENTAL
Intervention: Crawl couch (CrC)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Standard prone breastboard (BB)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Validation group (40 left and right‐sided breast cancer patients)
Number of subjects: 10
Study: 34240173

Group type: EXPERIMENTAL
Intervention: Erector spinae block
Number of subjects: 50

Group type: COMPARATOR
Intervention: Serratus plane block
Number of subjects: 50
Study: 34556166

Group type: EXPERIMENTAL
Intervention: Single-dose intravenous iron (two different formulations) administered early in the second trimester
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard doses of oral iron
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single-dose intravenous iron (two different formulations)
Number of subjects: 0
Study: 32189424

Group type: EXPERIMENTAL
Intervention: ICG fluorescence angiography (ICG FA)
Number of subjects: 377

Group type: COMPARATOR
Intervention: Non-ICG fluorescence angiography (visual clinical assessment)
Number of subjects: 377
Study: 33491093

Group type: EXPERIMENTAL
Intervention: Pulsed dye laser‐mediated photodynamic therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional red‐light photodynamic therapy
Number of subjects: 60
Study: 34246603

Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan
Number of subjects: 4796

Group type: COMPARATOR
Intervention: Valsartan
Number of subjects: 4796
Study: 33253622

Group type: EXPERIMENTAL
Intervention: Linguistic-phonological intervention
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Motor-phonetic intervention
Number of subjects: 14
Study: 36380126

Group type: EXPERIMENTAL
Intervention: Early withdrawal of life-sustaining treatments based on presumed poor neurologic prognosis (WLST-N)
Number of subjects: 1040

Group type: EXPERIMENTAL
Intervention: Factors associated with early WLST-N
Number of subjects: 1040

Group type: EXPERIMENTAL
Intervention: Institutional variation in early WLST-N
Number of subjects: 1040

Group type: EXPERIMENTAL
Intervention: Use of multimodal prognostication
Number of subjects: 1040

Group type: EXPERIMENTAL
Intervention: Use of sedative medications in patients with early WLST-N
Number of subjects: 1040